In Hae Park

7PUBLICATIONS

29CO-AUTHORS

Natural language processingMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 26, 2026

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

|Nov 22, 2023

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

David W Cescon, John Hilton, Serafin Morales Murilo

|Mar 09, 2021

Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.

Masakazu Toi, Kenichi Inoue, Norikazu Masuda

|Nov 10, 2019

Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response.

Jihyun Kim, Doyeong Yu, Youngmee Kwon

|Sep 19, 2019

Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer.

In Hae Park, Han Na Yang, Su Yeon Jeon

|Nov 20, 2018

Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.

Young Ae Kim, Hyunsoon Cho, Nayoung Lee

Pageof 2

Frequent Collaborators

Keun Seok Lee

Eun Sook Lee

Sun-Young Kong

Hak Jin Kim

Masakazu Toi

Norikazu Masuda

David W Cescon

John Hilton

Serafin Morales Murilo

1 joint publications

Rachel M Layman

Frequent Collaborators

Keun Seok Lee

Eun Sook Lee

Sun-Young Kong

Hak Jin Kim